Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant TuberculosisCHAHINE, Elias B; KARAOUI, Lamis R; MANSOUR, Hanine et al.The Annals of pharmacotherapy. 2014, Vol 48, Num 1, pp 107-115, issn 1060-0280, 9 p.Article

Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant TuberculosisWORLEY, Marylee V; ESTRADA, Sandy J.Pharmacotherapy. 2014, Vol 34, Num 11, pp 1187-1197, issn 0277-0008, 11 p.Article

A review of tuberculosis: Focus on bedaquilineCHAN, Bonnie; KHADEM, Tina M; BROWN, Jack et al.American journal of health-system pharmacy. 2013, Vol 70, Num 22, pp 1984-1994, issn 1079-2082, 11 p.Article

Les nouveaux antituberculeux (2): nouvelles molécules = New antituberculous drugs (2): New moleculesVEZIRIS, N.Journal des anti-infectieux. 2013, Vol 15, Num 3, pp 133-140, 8 p.Article

Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosisGUPTA, Shashank; COHEN, Keira A; WINGLEE, Kathryn et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 574-576, issn 0066-4804, 3 p.Article

Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosisHARTKOORN, Ruben C; UPLEKAR, Swapna; COLE, Stewart T et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2979-2981, issn 0066-4804, 3 p.Article

Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from IndiaUDWADIA, Z. F; AMALE, R. A; MULLERPATTAN, J. B et al.The International journal of tuberculosis and lung disease. 2014, Vol 18, Num 11, pp 1315-1318, issn 1027-3719, 4 p.Article

Bedaquiline contre la tuberculose multirésistante = Bedaquiline for multidrug-resistant tuberculosisThe Medical letter on drugs and therapeutics (Edition française). 2013, Vol 35, Num 19, pp 75-76, issn 0253-8512, 2 p.Article

Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary TuberculosisDIACON, Andreas H; DAWSON, Rodney; WINTER, Helen et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 5, pp 2199-2203, issn 0066-4804, 5 p.Article

bédaquiline ^(SIRTURO°): Un antituberculeux dangereux à mieux évaluerLa Revue Prescrire. 2014, Vol 34, Num 367, pp 337-340, issn 0247-7750, 4 p.Article

TRAITEMENTS ANTI-INFECTIEUX : RICAI, 33^e Réunion Interdisciplinaire de chimiothérapie anti-infectieuse, 21-22 novembre 2013, Paris - La DéfenseTATTEVIN, Pierre.La Lettre de l'infectiologue. 2014, Vol 29, Num 1, issn 0296-9009, 7 p., SUP2Serial Issue

À propos des ivacaftor, bédaquiline, florbétapir F18 et propranolol = Two news drugs (ivacaftor & bedaquiline), one biomarker (florbetapir) and a re-positioned drug (propranolol) on the marketMONNERET, C.Annales pharmaceutiques françaises. 2014, Vol 72, Num 4, pp 229-237, issn 0003-4509, 9 p.Article

Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and TuberculosisSVENSSON, Elin M; AWEEKA, Francesca; PARK, Jeong-Gun et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 6, pp 2780-2787, issn 0066-4804, 8 p.Article

Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers: AIDS Clinical Trials Group Study A5267DOOLEY, Kelly E; PARK, Jeong-Gun; QASBA, Sonia et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 5, pp 455-462, issn 1525-4135, 8 p.Article